Global and Japan Hospital-Acquired Disease Testing Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Hospital-Acquired Disease Testing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 UTI Testing
  • 1.2.3 SSI Testing
  • 1.2.4 Pneumococcal Infections Testing
  • 1.2.5 Bloodstream Infections Testing
  • 1.2.6 MRSA Testing
• 1.3 Market by Application
  • 1.3.1 Global Hospital-Acquired Disease Testing Market Share by Application: 2020 VS 2026
  • 1.3.2 Small and Medium Sized Hospitals
  • 1.3.3 Large Sized Hospitals
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Hospital-Acquired Disease Testing Market Perspective (2015-2026)
• 2.2 Global Hospital-Acquired Disease Testing Growth Trends by Regions
  • 2.2.1 Hospital-Acquired Disease Testing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Hospital-Acquired Disease Testing Historic Market Share by Regions (2015-2020)
  • 2.2.3 Hospital-Acquired Disease Testing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Hospital-Acquired Disease Testing Players by Market Size
  • 3.1.1 Global Top Hospital-Acquired Disease Testing Players by Revenue (2015-2020)
  • 3.1.2 Global Hospital-Acquired Disease Testing Revenue Market Share by Players (2015-2020)
• 3.2 Global Hospital-Acquired Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Hospital-Acquired Disease Testing Revenue
• 3.4 Global Hospital-Acquired Disease Testing Market Concentration Ratio
  • 3.4.1 Global Hospital-Acquired Disease Testing Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Hospital-Acquired Disease Testing Revenue in 2019
• 3.5 Key Players Hospital-Acquired Disease Testing Area Served
• 3.6 Key Players Hospital-Acquired Disease Testing Product Solution and Service
• 3.7 Date of Enter into Hospital-Acquired Disease Testing Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Hospital-Acquired Disease Testing Breakdown Data by Type (2015-2026)

• 4.1 Global Hospital-Acquired Disease Testing Historic Market Size by Type (2015-2020)
• 4.2 Global Hospital-Acquired Disease Testing Forecasted Market Size by Type (2021-2026)

5 Hospital-Acquired Disease Testing Breakdown Data by Application (2015-2026)

• 5.1 Global Hospital-Acquired Disease Testing Historic Market Size by Application (2015-2020)
• 5.2 Global Hospital-Acquired Disease Testing Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Hospital-Acquired Disease Testing Market Size (2015-2026)
• 6.2 North America Hospital-Acquired Disease Testing Market Size by Type (2015-2020)
• 6.3 North America Hospital-Acquired Disease Testing Market Size by Application (2015-2020)
• 6.4 North America Hospital-Acquired Disease Testing Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Hospital-Acquired Disease Testing Market Size (2015-2026)
• 7.2 Europe Hospital-Acquired Disease Testing Market Size by Type (2015-2020)
• 7.3 Europe Hospital-Acquired Disease Testing Market Size by Application (2015-2020)
• 7.4 Europe Hospital-Acquired Disease Testing Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Hospital-Acquired Disease Testing Market Size (2015-2026)
• 8.2 China Hospital-Acquired Disease Testing Market Size by Type (2015-2020)
• 8.3 China Hospital-Acquired Disease Testing Market Size by Application (2015-2020)
• 8.4 China Hospital-Acquired Disease Testing Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Hospital-Acquired Disease Testing Market Size (2015-2026)
• 9.2 Japan Hospital-Acquired Disease Testing Market Size by Type (2015-2020)
• 9.3 Japan Hospital-Acquired Disease Testing Market Size by Application (2015-2020)
• 9.4 Japan Hospital-Acquired Disease Testing Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Hospital-Acquired Disease Testing Market Size (2015-2026)
• 10.2 Southeast Asia Hospital-Acquired Disease Testing Market Size by Type (2015-2020)
• 10.3 Southeast Asia Hospital-Acquired Disease Testing Market Size by Application (2015-2020)
• 10.4 Southeast Asia Hospital-Acquired Disease Testing Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Diatherix Laboratories
  • 11.1.1 Diatherix Laboratories Company Details
  • 11.1.2 Diatherix Laboratories Business Overview
  • 11.1.3 Diatherix Laboratories Hospital-Acquired Disease Testing Introduction
  • 11.1.4 Diatherix Laboratories Revenue in Hospital-Acquired Disease Testing Business (2015-2020))
  • 11.1.5 Diatherix Laboratories Recent Development
• 11.2 Gen-Probe
  • 11.2.1 Gen-Probe Company Details
  • 11.2.2 Gen-Probe Business Overview
  • 11.2.3 Gen-Probe Hospital-Acquired Disease Testing Introduction
  • 11.2.4 Gen-Probe Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
  • 11.2.5 Gen-Probe Recent Development
• 11.3 Qiagen
  • 11.3.1 Qiagen Company Details
  • 11.3.2 Qiagen Business Overview
  • 11.3.3 Qiagen Hospital-Acquired Disease Testing Introduction
  • 11.3.4 Qiagen Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
  • 11.3.5 Qiagen Recent Development
• 11.4 F. Hoffmann-La Roche
  • 11.4.1 F. Hoffmann-La Roche Company Details
  • 11.4.2 F. Hoffmann-La Roche Business Overview
  • 11.4.3 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Introduction
  • 11.4.4 F. Hoffmann-La Roche Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
  • 11.4.5 F. Hoffmann-La Roche Recent Development
• 11.5 Cepheid
  • 11.5.1 Cepheid Company Details
  • 11.5.2 Cepheid Business Overview
  • 11.5.3 Cepheid Hospital-Acquired Disease Testing Introduction
  • 11.5.4 Cepheid Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
  • 11.5.5 Cepheid Recent Development
• 11.6 Life Technologies Corporation
  • 11.6.1 Life Technologies Corporation Company Details
  • 11.6.2 Life Technologies Corporation Business Overview
  • 11.6.3 Life Technologies Corporation Hospital-Acquired Disease Testing Introduction
  • 11.6.4 Life Technologies Corporation Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
  • 11.6.5 Life Technologies Corporation Recent Development
• 11.7 Meridian Biosciences
  • 11.7.1 Meridian Biosciences Company Details
  • 11.7.2 Meridian Biosciences Business Overview
  • 11.7.3 Meridian Biosciences Hospital-Acquired Disease Testing Introduction
  • 11.7.4 Meridian Biosciences Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
  • 11.7.5 Meridian Biosciences Recent Development
• 11.8 Cantel Medical Corporation
  • 11.8.1 Cantel Medical Corporation Company Details
  • 11.8.2 Cantel Medical Corporation Business Overview
  • 11.8.3 Cantel Medical Corporation Hospital-Acquired Disease Testing Introduction
  • 11.8.4 Cantel Medical Corporation Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
  • 11.8.5 Cantel Medical Corporation Recent Development
• 11.9 Nordion
  • 11.9.1 Nordion Company Details
  • 11.9.2 Nordion Business Overview
  • 11.9.3 Nordion Hospital-Acquired Disease Testing Introduction
  • 11.9.4 Nordion Revenue in Hospital-Acquired Disease Testing Business (2015-2020)
  • 11.9.5 Nordion Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer